Medical device externally used no risk or side effects. It decrease inflammation in chronic migraine reducing headache days by 80% . It also recedes fibromyalgia symptoms. It functions by downregulating the cytokine system and redirects arterial flow to the musculoskeletal and subcortical areas . We have 6 granted patents in the US and grate approved in th EU pending country designations we are hiring an experienced medical device CEO. We will be getting a formal prototype, then a CRO for clinical study and regulatory approval. Then manufacture and sale though a well recognized sale’s distributor channel. We expect to be class one and DTC through pharmacies and on lines. The market for chronic migraine is 10 m in the USabd $10B. The market for fibromyalgia is 10m patients US with high unmet need and palliative therapy and $10 B.
Ready to Ask For Funding for your company?
Post a Funding RequestCore Thermal is no longer seeking funding.